Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-γ, TNF-α, and low IL-10 production during the acute infection phase

Veterinary Immunology and Immunopathology

Volumn 130, Issue 1-2, 2009, Pages 43-52

  Guedes, Paulo M M ^a,c   Veloso, Vanja M ^b,c   Afonso, Luis C C ^c   Caliari, Marcelo V ^b   Carneiro, Cláudia M ^c   Diniz, Lívia F ^c   Marques da Silva, Eduardo A ^c   Caldas, Ivo S ^c   Do Valle Matta, Maria A ^d   Souza, Sheler M ^c   Lana, Marta ^c   Chiari, Egler ^b   Galvão, Lúcia M C ^b,e   Bahia, Maria T ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Chagas disease; Chronic cardiomyopathy; Cytokines; Dogs; Immunopathogenesis; T. cruzi

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CULTURE; CARDIOMEGALY; CARDIOMYOPATHY; CHAGAS DISEASE; CONTROLLED STUDY; DOG DISEASE; FIBROSIS; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LYMPHADENOPATHY; MYOCARDITIS; NONHUMAN; SPLENOMEGALY; TRYPANOSOMA CRUZI;

ANIMALS; CARDIOMEGALY; CHAGAS CARDIOMYOPATHY; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HISTOCYTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-10; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLENOMEGALY; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; CANIS FAMILIARIS; TRYPANOSOMA CRUZI;

EID: 67349207371     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.01.004     Document Type: Article

References (42)

1. Abel L.C., Rizzo L.V., Ianni B., Albuquerque F., Bacal F., Carrara D., Bocchi E.A., Teixeira H.C., Mady C., Kalil J., and Cunha-Neto E. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J. Autoimmun. 17 (2001) 99-107
2. Bahia-Oliveira L.M., Gomes J.A., Rocha M.O., Moreira M.C., Lemos E.M., Luz Z.M., Pereira M.E., Coffman R.L., Dias J.C., Cancado J.R., Gazzinelli G., and Correa-Oliveira R. IFN-gamma in human Chagas' disease: protection or pathology?. Braz. J. Med. Biol. Res. 31 (1998) 127-131
3. Bahia M.T., Tafuri W.L., Caliari M.V., Veloso V.M., Carneiro C.M., Coelho G.L., and Lana M. Comparison of Trypanosoma cruzi infection in dogs inoculated with blood or metacyclic trypomastigotes of Berenice-62 and Berenice-78 strains via intraperitoneal and conjunctival routes. Rev. Soc. Bras. Med. Trop. 35 (2002) 339-345
4. Brener Z. Comparative studies of different strains of Trypanosoma cruzi. Ann. Trop. Med. Parasitol. 59 (1965) 19-26
5. Caliari M.V., do Pilar Machado R., de Lana M., Caja R.A., Carneiro C.M., Bahia M.T., dos Santos C.A., Magalhaes G.A., Sampaio I.B., and Tafuri W.L. Quantitative analysis of cardiac lesions in chronic canine chagasic cardiomyopathy. Rev. Inst. Med. Trop. Sao Paulo 44 (2002) 273-278
6. Correa-Oliveira R., Gomes J., Lemos E.M., Cardoso G.M., Reis D.D., Adad S., Crema E., Martins-Filho O.A., Costa M.O., Gazzinelli G., and Bahia-Oliveira L.M. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem. Inst. Oswaldo Cruz 94 (1999) 253-255
7. Cunha-Neto E., Rizzo L.V., Albuquerque F., Abel L., Guilherme L., Bocchi E., Bacal F., Carrara D., Ianni B., Mady C., and Kalil J. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz. J. Med. Biol. Res. 31 (1998) 133-137
8. Dias J.C. The indeterminate form of human chronic Chagas' disease a clinical epidemiological review. Rev. Soc. Bras. Med. Trop. 22 (1989) 147-156
9. Dutra W.O., Gollob K.J., Pinto-Dias J.C., Gazzinelli G., Correa-Oliveira R., Coffman R.L., and Carvalho-Parra J.F. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand. J. Immunol. 45 (1997) 74-80
10. Eksi S., Wassom D.L., and Powell M.R. Host genetics and resistance to acute Trypanosoma cruzi infection in mice: profiles and compartmentalization of IL-2-, -4-, -5-, -10-, and IFN-gamma-producing cells. J. Parasitol. 82 (1996) 59-65
11. Elizari M.V., and Chiale P.A. Cardiac arrhythmias in Chagas' heart disease. J. Cardiovasc. Electrophysiol. 4 (1993) 596-608
12. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., and Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 71 (2003) 1185-1193
13. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Busek S.C., Teixeira M.M., Silva J.S., and Correa-Oliveira R. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect. Immun. 73 (2005) 7960-7966
14. Guedes P.M., Veloso V.M., Caliari M.V., Carneiro C.M., Souza S.M., de Lana M., Chiari E., Bahia M.T., and Galvao L.M. Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs. Mem. Inst. Oswaldo Cruz 102 (2007) 141-147
15. Guedes P.M., Veloso V.M., Gollob K.J., Afonso L.C., Caldas I.S., Vianna P., de Lana M., Chiari E., Bahia M.T., and Galvao L.M. IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct Trypanosoma cruzi strains. Vet. Immunol. Immunopathol. 124 (2008) 163-168
16. Higuchi M.D. Endomyocardial biopsy in Chagas' heart disease: pathogenetic contributions. Sao Paulo Med. J. 113 (1995) 821-825
17. Higuchi M.D., Ries M.M., Aiello V.D., Benvenuti L.A., Gutierrez P.S., Bellotti G., and Pileggi F. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am. J. Trop. Med. Hyg. 56 (1997) 485-489
18. Higuchi M.L. Chronic chagasic cardiopathy: the product of a turbulent host-parasite relationship. Rev. Inst. Med. Trop. Sao Paulo 39 (1997) 53-60
19. Holscher C., Kohler G., Muller U., Mossmann H., Schaub G.A., and Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66 (1998) 1208-1215
20. Lana M., and Chiari C.A. Comparative biological characterization of Berenice and Berenice-78 strains of Trypanosoma cruzi isolated from the same patient at different times. Mem. Inst. Oswaldo Cruz 81 (1986) 247-253
21. Lana M., Chiari E., and Tafuri W.L. Experimental Chagas' disease in dogs. Mem. Inst. Oswaldo Cruz 87 (1992) 59-71
22. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., and Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102 (2000) 3003-3008
23. Maltos K.L., Menezes G.B., Caliari M.V., Rocha O.A., Santos J.M., Alves D.L., Duarte I.D., and Francischi J.N. Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp. Arch. Oral Biol. 49 (2004) 443-450
24. Pereira Barretto A.C., Mady C., Arteaga-Fernandez E., Stolf N., Lopes E.A., Higuchi M.L., Bellotti G., and Pileggi F. Right ventricular endomyocardial biopsy in chronic Chagas' disease. Am. Heart J. 111 (1986) 307-312
25. Powell M.R., Morgan J., Guarner J., and Colley D.G. Cytokine mRNA levels in the hearts of inbred mice that develop different degrees of cardiomyopathy during infection with Trypanosoma cruzi. Parasite Immunol. 20 (1998) 463-471
26. Ramasawmy R., Cunha-Neto E., Fae K.C., Martello F.G., Muller N.G., Cavalcanti V.L., Ianni B., Mady C., Kalil J., and Goldberg A.C. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clin. Infect. Dis. 43 (2006) 305-311
27. Rassi Jr. A., Rassi A., and Little W.C. Chagas' heart disease. Clin. Cardiol. 23 (2000) 883-889
28. Reis D.D., Gazzinelli R.T., Gazzinelli G., and Colley D.G. Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease. J. Immunol. 150 (1993) 1611-1618
29. Reis M.M., Higuchi Mde L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., and Pileggi F. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin. Immunol. Immunopathol. 83 (1997) 165-172
30. Ribeirao M., Pereira-Chioccola V.L., Renia L., Augusto Fragata Filho A., Schenkman S., and Rodrigues M.M. Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol. 22 (2000) 49-53
31. Salgado J.A., Garcez P.N., de O.C., and Galizzi J. Current clinical review of the 1st described human case of Chagas' disease. Rev. Inst. Med. Trop. Sao Paulo 4 (1962) 330-337
32. Santos F.R., Pena S.D., and Epplen J.T. Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique. Hum. Genet. 90 (1993) 655-656
33. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., and Reed S.G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175 (1992) 169-174
34. Silva L., and Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 20 (1953) 191-203
35. Snedecor G., and Cochran W. Statistical Methods (1989), Yowa State University Press 503 pp
36. Souza P.E., Rocha M.O., Rocha-Vieira E., Menezes C.A., Chaves A.C., Gollob K.J., and Dutra W.O. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect. Immun. 72 (2004) 5283-5291
37. Tafuri W.L. Pathogenesis of lesions of the autonomic nervous system of the mouse in experimental acute Chagas' disease. Light and electron microscope studies. Am. J. Trop. Med. Hyg. 19 (1970) 405-417
38. Tafuri W.L. Pathogenesis of Chagas disease. Rev. Inst. Med. Trop. Sao Paulo 29 (1987) 194-199
39. Teixeira M.M., Gazzinelli R.T., and Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18 (2002) 262-265
40. Veloso V.M., Carneiro C.M., Toledo M.J., Lana M., Chiari E., Tafuri W.L., and Bahia M.T. Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Mem. Inst. Oswaldo Cruz 96 (2001) 1005-1011
41. Waghabi M.C., Coutinho C.M., Soeiro M.N., Pereira M.C., Feige J.J., Keramidas M., Cosson A., Minoprio P., Van Leuven F., and Araujo-Jorge T.C. Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin. Infect. Immun. 70 (2002) 5115-5123
42. Zhang L., and Tarleton R.L. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur. J. Immunol. 26 (1996) 102-109